CD8A and neoplasm: Recent studies have found that blocking the sphingolipid production pathway in cancer cells, especially through the regulation of interferon-γ (IFN-γ) signaling pathway, can effectively enhance the anti-tumor proliferation efficacy of natural killer cells and CD8+T cells 214.